Praxis Home Retail Ltd.
Praxis Home Retail Ltd. (PRAXIS-RE.NS) Stock Competitors & Peer Comparison
See (PRAXIS-RE.NS) competitors and their performances in Stock Market.
Peer Comparison Table: Specialty Retail Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PRAXIS-RE.NS | ₹15.00 | +0.00% | 0 | N/A | N/A | N/A |
| ETERNAL.BO | ₹229.05 | -1.74% | 2.1T | 995.87 | ₹0.23 | N/A |
| ZOMATO.NS | ₹215.19 | +0.00% | 2T | 286.92 | ₹0.75 | N/A |
| ZOMATO.BO | ₹215.25 | +0.00% | 2T | 377.63 | ₹0.57 | N/A |
| SWIGGY.NS | ₹260.05 | -3.17% | 675.2B | -13.95 | -₹18.64 | N/A |
| SWIGGY.BO | ₹259.85 | -3.08% | 674.7B | -13.95 | -₹18.63 | N/A |
| NYKAA.BO | ₹235.20 | -1.82% | 673.4B | 490.00 | ₹0.48 | N/A |
| NYKAA.NS | ₹235.00 | -1.94% | 672.9B | 489.58 | ₹0.48 | N/A |
| AVL.NS | ₹478.10 | -2.27% | 61.7B | 55.85 | ₹8.56 | +0.23% |
| REDTAPE.NS | ₹109.93 | -2.67% | 60.8B | 28.63 | ₹3.84 | +0.68% |
Stock Comparison
PRAXIS-RE.NS vs ETERNAL.BO Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, ETERNAL.BO has a market cap of 2.1T. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while ETERNAL.BO trades at ₹229.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas ETERNAL.BO's P/E ratio is 995.87. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to ETERNAL.BO's ROE of +0.01%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to ETERNAL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check ETERNAL.BO's competition here
PRAXIS-RE.NS vs ZOMATO.NS Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, ZOMATO.NS has a market cap of 2T. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while ZOMATO.NS trades at ₹215.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas ZOMATO.NS's P/E ratio is 286.92. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to ZOMATO.NS's ROE of +0.01%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to ZOMATO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check ZOMATO.NS's competition here
PRAXIS-RE.NS vs ZOMATO.BO Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, ZOMATO.BO has a market cap of 2T. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while ZOMATO.BO trades at ₹215.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas ZOMATO.BO's P/E ratio is 377.63. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to ZOMATO.BO's ROE of +0.01%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to ZOMATO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check ZOMATO.BO's competition here
PRAXIS-RE.NS vs SWIGGY.NS Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, SWIGGY.NS has a market cap of 675.2B. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while SWIGGY.NS trades at ₹260.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas SWIGGY.NS's P/E ratio is -13.95. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to SWIGGY.NS's ROE of -0.48%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to SWIGGY.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check SWIGGY.NS's competition here
PRAXIS-RE.NS vs SWIGGY.BO Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, SWIGGY.BO has a market cap of 674.7B. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while SWIGGY.BO trades at ₹259.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas SWIGGY.BO's P/E ratio is -13.95. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to SWIGGY.BO's ROE of -0.48%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to SWIGGY.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check SWIGGY.BO's competition here
PRAXIS-RE.NS vs NYKAA.BO Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, NYKAA.BO has a market cap of 673.4B. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while NYKAA.BO trades at ₹235.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas NYKAA.BO's P/E ratio is 490.00. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to NYKAA.BO's ROE of +0.11%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to NYKAA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check NYKAA.BO's competition here
PRAXIS-RE.NS vs NYKAA.NS Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, NYKAA.NS has a market cap of 672.9B. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while NYKAA.NS trades at ₹235.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas NYKAA.NS's P/E ratio is 489.58. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to NYKAA.NS's ROE of +0.11%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to NYKAA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check NYKAA.NS's competition here
PRAXIS-RE.NS vs AVL.NS Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, AVL.NS has a market cap of 61.7B. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while AVL.NS trades at ₹478.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas AVL.NS's P/E ratio is 55.85. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to AVL.NS's ROE of +0.19%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to AVL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check AVL.NS's competition here
PRAXIS-RE.NS vs REDTAPE.NS Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, REDTAPE.NS has a market cap of 60.8B. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while REDTAPE.NS trades at ₹109.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas REDTAPE.NS's P/E ratio is 28.63. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to REDTAPE.NS's ROE of +0.27%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to REDTAPE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check REDTAPE.NS's competition here
PRAXIS-RE.NS vs RTNINDIA.BO Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, RTNINDIA.BO has a market cap of 35.4B. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while RTNINDIA.BO trades at ₹25.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas RTNINDIA.BO's P/E ratio is -8.60. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to RTNINDIA.BO's ROE of -0.38%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to RTNINDIA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check RTNINDIA.BO's competition here
PRAXIS-RE.NS vs EMIL.BO Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, EMIL.BO has a market cap of 33.9B. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while EMIL.BO trades at ₹88.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas EMIL.BO's P/E ratio is 36.28. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to EMIL.BO's ROE of +0.06%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to EMIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check EMIL.BO's competition here
PRAXIS-RE.NS vs EMIL.NS Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, EMIL.NS has a market cap of 33.9B. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while EMIL.NS trades at ₹88.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas EMIL.NS's P/E ratio is 36.26. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to EMIL.NS's ROE of +0.06%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to EMIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check EMIL.NS's competition here
PRAXIS-RE.NS vs GARGI.BO Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, GARGI.BO has a market cap of 8B. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while GARGI.BO trades at ₹768.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas GARGI.BO's P/E ratio is 26.49. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to GARGI.BO's ROE of +0.29%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to GARGI.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check GARGI.BO's competition here
PRAXIS-RE.NS vs LOGICA.BO Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, LOGICA.BO has a market cap of 3.2B. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while LOGICA.BO trades at ₹181.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas LOGICA.BO's P/E ratio is 23.06. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to LOGICA.BO's ROE of N/A. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to LOGICA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check LOGICA.BO's competition here
PRAXIS-RE.NS vs KDML.BO Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, KDML.BO has a market cap of 3.1B. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while KDML.BO trades at ₹132.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas KDML.BO's P/E ratio is 15.75. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to KDML.BO's ROE of +0.16%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to KDML.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check KDML.BO's competition here
PRAXIS-RE.NS vs PANORAMA.BO Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, PANORAMA.BO has a market cap of 2.4B. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while PANORAMA.BO trades at ₹32.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas PANORAMA.BO's P/E ratio is 21.73. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to PANORAMA.BO's ROE of +0.20%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to PANORAMA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check PANORAMA.BO's competition here
PRAXIS-RE.NS vs COMPEAU.BO Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, COMPEAU.BO has a market cap of 2B. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while COMPEAU.BO trades at ₹328.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas COMPEAU.BO's P/E ratio is 10.46. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to COMPEAU.BO's ROE of +0.05%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to COMPEAU.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check COMPEAU.BO's competition here
PRAXIS-RE.NS vs AAYUSH.BO Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, AAYUSH.BO has a market cap of 1.3B. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while AAYUSH.BO trades at ₹27.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas AAYUSH.BO's P/E ratio is 30.10. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to AAYUSH.BO's ROE of +0.54%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to AAYUSH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check AAYUSH.BO's competition here
PRAXIS-RE.NS vs PRAXIS.BO Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, PRAXIS.BO has a market cap of 1B. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while PRAXIS.BO trades at ₹5.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas PRAXIS.BO's P/E ratio is 2.77. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to PRAXIS.BO's ROE of -1.13%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to PRAXIS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check PRAXIS.BO's competition here
PRAXIS-RE.NS vs KEMP.BO Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, KEMP.BO has a market cap of 987.2M. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while KEMP.BO trades at ₹913.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas KEMP.BO's P/E ratio is -62.90. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to KEMP.BO's ROE of -0.01%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to KEMP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check KEMP.BO's competition here
PRAXIS-RE.NS vs PRAXIS.NS Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, PRAXIS.NS has a market cap of 979.2M. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while PRAXIS.NS trades at ₹5.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas PRAXIS.NS's P/E ratio is 2.61. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to PRAXIS.NS's ROE of -1.13%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to PRAXIS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check PRAXIS.NS's competition here
PRAXIS-RE.NS vs LLOYDS.NS Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, LLOYDS.NS has a market cap of 939.5M. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while LLOYDS.NS trades at ₹39.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas LLOYDS.NS's P/E ratio is -1.40. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to LLOYDS.NS's ROE of N/A. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to LLOYDS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check LLOYDS.NS's competition here
PRAXIS-RE.NS vs ISFT.NS Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, ISFT.NS has a market cap of 906.1M. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while ISFT.NS trades at ₹55.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas ISFT.NS's P/E ratio is 7.25. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to ISFT.NS's ROE of +0.05%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to ISFT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check ISFT.NS's competition here
PRAXIS-RE.NS vs ISFT.BO Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, ISFT.BO has a market cap of 903.3M. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while ISFT.BO trades at ₹55.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas ISFT.BO's P/E ratio is 7.23. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to ISFT.BO's ROE of +0.05%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to ISFT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check ISFT.BO's competition here
PRAXIS-RE.NS vs DIGIDRIVE.NS Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, DIGIDRIVE.NS has a market cap of 648.2M. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while DIGIDRIVE.NS trades at ₹16.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas DIGIDRIVE.NS's P/E ratio is 5.22. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to DIGIDRIVE.NS's ROE of +0.04%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to DIGIDRIVE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check DIGIDRIVE.NS's competition here
PRAXIS-RE.NS vs ARCHIES.BO Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, ARCHIES.BO has a market cap of 374.6M. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while ARCHIES.BO trades at ₹11.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas ARCHIES.BO's P/E ratio is -35.77. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to ARCHIES.BO's ROE of -0.01%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to ARCHIES.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check ARCHIES.BO's competition here
PRAXIS-RE.NS vs ARCHIES.NS Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, ARCHIES.NS has a market cap of 374.3M. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while ARCHIES.NS trades at ₹11.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas ARCHIES.NS's P/E ratio is -33.58. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to ARCHIES.NS's ROE of -0.01%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to ARCHIES.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check ARCHIES.NS's competition here
PRAXIS-RE.NS vs PACE.BO Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, PACE.BO has a market cap of 290.7M. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while PACE.BO trades at ₹12.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas PACE.BO's P/E ratio is 7.09. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to PACE.BO's ROE of +0.05%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to PACE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check PACE.BO's competition here
PRAXIS-RE.NS vs DUKEOFS.BO Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, DUKEOFS.BO has a market cap of 239.2M. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while DUKEOFS.BO trades at ₹24.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas DUKEOFS.BO's P/E ratio is -42.58. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to DUKEOFS.BO's ROE of -0.12%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to DUKEOFS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check DUKEOFS.BO's competition here
PRAXIS-RE.NS vs UHZAVERI.BO Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, UHZAVERI.BO has a market cap of 120.3M. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while UHZAVERI.BO trades at ₹12.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas UHZAVERI.BO's P/E ratio is -301.75. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to UHZAVERI.BO's ROE of +0.00%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to UHZAVERI.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check UHZAVERI.BO's competition here
PRAXIS-RE.NS vs DARSHANORNA.BO Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, DARSHANORNA.BO has a market cap of 116.9M. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while DARSHANORNA.BO trades at ₹2.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas DARSHANORNA.BO's P/E ratio is 48.40. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to DARSHANORNA.BO's ROE of +0.03%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to DARSHANORNA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check DARSHANORNA.BO's competition here
PRAXIS-RE.NS vs RAJPUTANA.BO Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, RAJPUTANA.BO has a market cap of 96.4M. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while RAJPUTANA.BO trades at ₹31.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas RAJPUTANA.BO's P/E ratio is 78.25. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to RAJPUTANA.BO's ROE of +0.03%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to RAJPUTANA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check RAJPUTANA.BO's competition here
PRAXIS-RE.NS vs DDIL.BO Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, DDIL.BO has a market cap of 95.1M. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while DDIL.BO trades at ₹1.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas DDIL.BO's P/E ratio is 4.42. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to DDIL.BO's ROE of +0.26%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to DDIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check DDIL.BO's competition here
PRAXIS-RE.NS vs HARIAEXPO.BO Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, HARIAEXPO.BO has a market cap of 76.7M. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while HARIAEXPO.BO trades at ₹6.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas HARIAEXPO.BO's P/E ratio is 55.33. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to HARIAEXPO.BO's ROE of +0.01%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to HARIAEXPO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check HARIAEXPO.BO's competition here
PRAXIS-RE.NS vs VEERKRUPA.BO Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, VEERKRUPA.BO has a market cap of 72.1M. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while VEERKRUPA.BO trades at ₹0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas VEERKRUPA.BO's P/E ratio is 27.50. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to VEERKRUPA.BO's ROE of +0.01%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to VEERKRUPA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check VEERKRUPA.BO's competition here
PRAXIS-RE.NS vs MHSGRMS.BO Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, MHSGRMS.BO has a market cap of 52.7M. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while MHSGRMS.BO trades at ₹6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas MHSGRMS.BO's P/E ratio is 7.79. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to MHSGRMS.BO's ROE of -2.38%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to MHSGRMS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check MHSGRMS.BO's competition here
PRAXIS-RE.NS vs JSHL.BO Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, JSHL.BO has a market cap of 52.4M. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while JSHL.BO trades at ₹8.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas JSHL.BO's P/E ratio is -11.88. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to JSHL.BO's ROE of -0.02%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to JSHL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check JSHL.BO's competition here
PRAXIS-RE.NS vs SPECTRA.BO Comparison April 2026
PRAXIS-RE.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS-RE.NS stands at 0. In comparison, SPECTRA.BO has a market cap of 36.9M. Regarding current trading prices, PRAXIS-RE.NS is priced at ₹15.00, while SPECTRA.BO trades at ₹5.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS-RE.NS currently has a P/E ratio of N/A, whereas SPECTRA.BO's P/E ratio is -1.50. In terms of profitability, PRAXIS-RE.NS's ROE is N/A, compared to SPECTRA.BO's ROE of +0.07%. Regarding short-term risk, PRAXIS-RE.NS is more volatile compared to SPECTRA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS-RE.NS.Check SPECTRA.BO's competition here